Article Text

PDF

Agreement between an arterial blood gas analyser and a venous blood analyser in the measurement of potassium in patients in cardiac arrest
  1. H L M Johnston1,
  2. R Murphy2
  1. 1The Faculty of Medicine, University of Edinburgh, Edinburgh, UK
  2. 2Accident and Emergency Department, Royal Infirmary of Edinburgh, Edinburgh, UK
  1. Correspondence to:
 R Murphy
 rossmurphydoctors.org.uk

Abstract

Background and objective: Rapid measurement of potassium is crucial in the resuscitation of patients in cardiac arrest. This is often done on an arterial blood gas sample taken during resuscitation and analysed in an emergency department based blood gas analyser. No-one has assessed how accurate or reliable this is when compared with the traditional method of sending a venous sample to the laboratory for standard analysis. This study looked at the agreement between potassium measurements in arterial blood gas samples and venous blood samples in patients in cardiac arrest.

Method: Arterial and venous blood samples were taken at the same time and analysed in the usual way from 50 patients in cardiac arrest. It was found that the mean difference between each pair of arterial and venous potassium measurements was low at 0.106 mmol/l. However, the standard deviation of these dif-ferences and subsequently the 95% limits of agreement were wide (−1.182 mmol/l to 1.394 mmol/l)—that is, 95% of differences will lie between these limits. It is felt that these limits are too wide for safe use in clinical practice.

Conclusion: Based on these results, it is advised that arterial blood gas analysers should be used with caution to measure potassium in patients in cardiac arrest.

  • cardiac arrest
  • potassium
  • resuscitation
View Full Text

Statistics from Altmetric.com

Abnormalities of potassium concentration are considered reversible causes of cardiac arrest.1 Hyperkalaemia causes hyperpolarisation of the heart, bradycardia, and asystole. Hypokalaemia, especially in the setting of heart disease and digoxin toxicity, causes fatal cardiac arrhythmias. In addition, the potassium concentration in blood frequently changes during the course of a resuscitation. Just after cardiac arrest the concentration rises due to the release of potassium from underperfused cells. Then, as resuscitation gets underway, there is often a rebound fall as the circulation is restored and endogenous adrenaline and exogenous drugs take effect.2

It is, therefore, important to measure potassium as soon as possible during the course of a resuscitation. This has traditionally been done by taking a venous sample and sending it to the biochemistry laboratory for standard analysis. This, however, can take some time. Many people now prefer to measure potassium on an arterial blood gas sample in a resuscitation room based blood gas analyser. This gives a much faster result, but it is not known how accurate this is when compared with a venous measurement.

In this study we aimed to determine the agreement between potassium measurements in venous and arterial blood gas samples in patients in cardiac arrest.

MATERIALS AND METHODS

The emergency department records of patients who presented in cardiac arrest over a 10 month period in 2001 were traced and examined. A sample size of 50 was considered appropriate as this is the minimum sample size recommended for a method comparison study.3 Patients were selected on the basis of both their arterial blood gas and venous laboratory blood results being available. This involved searching through emergency department, medical, and laboratory records until such records for 50 patients were obtained.

At our hospital during resuscitation the arterial and venous blood samples are collected from either the radial or femoral artery and a vein. The arterial sample is taken directly into a preheparinised syringe and placed immediately in the arterial blood gas analyser in the resuscitation room (IL1640 Blood Gas Analyser). It takes approximately two minutes for the results to be ready. The venous sample is collected and sent to a central laboratory in the hospital, via a tube transport system, for analysis (Olympus Analyser). It takes approximately 40 minutes for the results to be uploaded onto the hospital computer system or they can be obtained slightly more quickly via telephone.

For the present study both sets of results were checked to make sure the dates and times of collection matched for each patient. For venous samples the time recorded was the time at which the blood samples were received by the laboratory as an emergency sample. For arterial samples the time taken was the time at which the samples were analysed by the arterial blood gas analyser. These times were checked to ensure that there was never more than 10 minutes between them and the time at which the patient was recorded as entering the resuscitation room. These three times were recorded automatically by the laboratory and by the arterial blood gas analyser, and in the nursing notes, respectively.

The measurements for each patient were entered in a database for statistical analysis using Microsoft Excel for Windows (version 4.0, 1985–1997 Microsoft Corp, USA) and compared using methods described by Altman for assessing the agreement between two methods of clinical measurement.3

RESULTS

Both potassium measurements for each patient are given in table 1.

Table 1

 Arterial and venous potassium levels of 50 patients in cardiac arrest.

The arterial potassium measurements ranged between 2.7 mmol/l and 6.7 mmol/l (mean 4.17 mmol/l). The venous measurements ranged between 2.5 mmol/l and 6.3 mmol/l (mean 4.06 mmol/l). Pearson’s correlation coefficient between the venous and arterial measurements was 0.73.

These measurements were plotted against each other with the line of equality (fig 1). The line of equality is the line along which all points would lie if there was exact agreement.

Figure 1

 Arterial and venous potassium measurements with the line of equality.

We analysed the results further to better assess the agreement. The differences between each pair of arterial and venous measurements ranged between −0.9 mmol/l and 3.4 mmol/l (mean (SD) 0.106 mmol/l (0.644 mmol/l)). Two standard deviations above and below this mean are the 95% limits of agreement; 95% of differences will lie within these limits. We calculated these limits as −1.182 mmol/l and 1.394 mmol/l (see fig 2 which plots the mean between each arterial and venous potassium measurement against the difference).

Figure 2

 Difference against mean for each arterial and venous potassium measurement. The mean difference ± 2 SD is shown by dotted lines.

DISCUSSION

The speed with which test results become available has received a lot of attention recently with the development of near patient tests for a variety of clinical conditions. It is felt that because less time is spent waiting for results and because fewer staff are involved in processing each test this has benefits for patients and clinicians and that it is more cost effective, However, there is still some doubt about their accuracy and reliability with only 34% of clinicians in one study using them to guide patient care.4

Faster results are nowhere more important than in the emergency department where rule out and rule in strategies are needed to process different patient presentations. This is especially true in cardiac arrest when identifying treatable causes of the arrest is given a high priority. Arterial blood gas analysers are now regularly used to measure potassium in these situations. Our results show that the mean difference between each arterial and venous potassium measurement is low at 0.106 mmol/l. However, the 95% limits of agreement were −1.182 mmol/l to +1.394 mmol/l, which may be too wide for safe use in clinical practice. These results are consistent with a previous report which also identified wide limits of agreement although in a sample of intensive care patients.5

There are a number of possible reasons for this poor agreement. We used different analysers for the arterial and venous samples so a lack of agreement between the analysers themselves may account for some of the differences. The accuracy of all laboratory equipment, however, is now upheld by regular calibration and quality control procedures and the machines used in this study were maintained according to the manufacturers’ instructions. As the heparinised arterial sample is plasma and the venous sample is serum this would also account for some of the differences. A previous study, albeit with a small number of patients, found that the mean difference between plasma and serum potassium measured on the same analyser was 0.5 mmol/l with a range of 0.1–1.1 mmol/l. The measurements were always higher in the venous sample.6

The two samples are also taken in different ways from different parts of an impaired blood circulation and this may give rise to further discrepancies. For the present study we felt as this was how the two measurements were made in real life it was important that this was how the results should be analysed.

The differences in this study, however, ranged between −0.9 mmol/l and 3.4 mmol/l. Some of these differences are too large to be explained by the above. We think that the main reason for such large differences is unrecognised haemolysis in the arterial sample. The venous samples sent to the laboratory are always centrifuged and then inspected visually for haemolysis. When haemolysis is detected the sample is discarded or no measurement is given for potassium. In our study these patients would therefore have been excluded. The arterial sample is not screened for haemolysis. It is put into the analyser and a potassium measurement is obtained regardless. The mean difference between our arterial and venous samples was positive indicating that potassium was usually measured higher in the arterial sample. In addition, whenever large differences occurred it was always the arterial potassium that was higher which supports our conclusions.

Our study did not aim to establish the effect of these differences on patient care and outcome and any risk at present remains theoretical. However, we feel that if a false high potassium result is obtained for a patient in cardiac arrest who has a low or normal potassium this could result in inappropriate or no treatment when action is urgently needed.

As a result of this study, we advise caution when using arterial blood gas analysers to measure potassium in patients in cardiac arrest. In future it may be useful to develop a means to identify haemolysis in arterial blood gas samples to eliminate potentially unreliable results.

REFERENCES

View Abstract

Footnotes

  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.